Explore evidence

12 %In the Dar-es-Salaam cohort study, 209 (12%) Sickle Cell Anemia patients were lost to follow up.

Tanzaniedrépanocytosepublished 2011PloS oneeurope_pmcdocument of 7 observations

10.3 %SARS-CoV-2 prevalence was 10.3% among people living without HIV and 6.3% among persons living with HIV in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations

7.54 timesPersons with diagnosed diabetes had 7.54 times more outpatient visits than matched comparison subjects without diabetes in Cameroon, Mali, Tanzania and South Africa during 2008–2009.

Afrique du Sud · Cameroun · Mali · Tanzaniediabète (non précisé)observed 2008–2009published 2014PloS oneeurope_pmcdocument of 3 observations

2.36 RRIn Namtumbo district, the relative risk (RR) for under-five mortality was estimated at 2.36.

Tanzaniemortalité infanto-juvénileobserved 2022HAL · Unilimdocument of 238 observations

13 %Mortality was 13% in patients with Plasmodium falciparum parasitaemia.

Tanzaniepaludismeobserved October 2000 to July 2001published 2003QJM : monthly journal of the Association of Physicianseurope_pmcdocument of 7 observations

23 %Two-week all-cause mortality in the DREAMM cohort of 148 participants with cryptococcal meningitis from Cameroon, Malawi, and Tanzania was 23%.

Cameroun · Malawi · Tanzanieméningite cryptococciqueHAL · Unilimdocument of 205 observations

97.3 %Dried blood spot HCV core antigen testing had a specificity of 97.3% compared to HCV nucleic acid testing as reference.

Tanzaniehépatite Cobserved 2015published 2017Journal of the International AIDS Societyeurope_pmcdocument of 9 observationsDOI 10.7448/ias.20.1.21856

4.6 %Under-five mortality in Tanzania was 4.6% among children from households with unimproved toilet facilities.

Tanzaniemortalité infanto-juvénileHAL · Unilimdocument of 238 observations

66.7 %Multi-drug resistance proportion was 66.7% for Staphylococcus aureus isolates.

Tanzaniedrépanocytosepublished 2022Infection and drug resistanceeurope_pmcdocument of 10 observationsDOI 10.2147/idr.s367873

77.5 %Mass drug administration was expected to reduce malaria prevalence by 77.5%.

Tanzaniepaludismepublished 2020PloS oneeurope_pmcdocument of 8 observationsDOI 10.1371/journal.pone.0228469

Among children with sickle cell anaemia, hydroxyurea utilization accessed via insurance and projects led to a significant reduction in the proportion of patients reporting vaso-occlusive crisis, admissions, and blood transfusions.

Tanzaniedrépanocytosepublished 2023Journal of blood medicineeurope_pmcdocument of 11 observations

6.3 %SARS-CoV-2 prevalence was 6.3% among persons living with HIV in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations

4.17 odds_ratioSCA was associated with an increased risk of admission to hospital with nonmalaria diseases in general (odds ratio = 4.17).

Tanzaniedrépanocytose · nonmalaria diseasespublished 2010Bloodeurope_pmcdocument of 5 observationsDOI 10.1182/blood-2010-01-265249

99 monthsThe median age at baseline among children with sickle cell anaemia was 99 months.

Tanzaniedrépanocytosepublished 2023Journal of blood medicineeurope_pmcdocument of 11 observations

7 %Of the 1245 patients included in the study, 7% were sputum smear positive at two months of anti-tuberculosis therapy.

Tanzanietuberculosepublished 2014PloS oneeurope_pmcdocument of 3 observations

0.83 RRIn Magu district, the relative risk (RR) for under-five mortality was 0.83.

Tanzaniemortalité infanto-juvénileobserved 2022HAL · Unilimdocument of 238 observations

2.11 SMRIn Mbogwe district, the standardized mortality ratio (SMR) for under-five mortality was estimated at 2.11.

Tanzaniemortalité infanto-juvénileobserved 2022HAL · Unilimdocument of 238 observations

0.82 RRIn Bariadi district, the relative risk (RR) for under-five mortality was 0.82.

Tanzaniemortalité infanto-juvénileobserved 2022HAL · Unilimdocument of 238 observations

Active case search data from June 2026 revealed a high burden of unreported suspected VPDs, primarily measles, concentrated in the East and Southern Africa Block (Mozambique, Malawi, Tanzania, Ethiopia, Kenya, Zambia, and Madagascar), in the DRC-Angola Block (DRC and Angola), in the West Block (Benin, Togo and Guinea), and in the Lake Chad Basin (Nigeria, Chad, Cameroon and Central African Republic).

Angola · Bénin · Cameroun · Éthiopie · Guinée · Kenya · Madagascar · Malawi · Mozambique · Nigeria · RDC · Tanzanie · Tchad · Togo · Zambierougeole · VPDsobserved June 2026WHO Africadocument of 17 observations

8.73 odds_ratioSCA was associated with an increased risk of admission to hospital with invasive bacterial diseases (odds ratio = 8.73).

Tanzaniedrépanocytose · invasive bacterial diseasespublished 2010Bloodeurope_pmcdocument of 5 observationsDOI 10.1182/blood-2010-01-265249

5.6 %Une étude tanzanienne récente a rapporté une proportion de 5,6 % de femmes présentant des anomalies mammaires détectées par examen clinique du sein.

Tanzanieanomalies mammairesHAL · Unilimdocument of 17 observations

11 %Increased HbF percentage correlated with reduced odds of multiple blood transfusions by 11%.

Tanzaniedrépanocytosepublished 2025Journal of blood medicineeurope_pmcdocument of 5 observations

89.1 %Eighty-two patients (89.1%) had HbF/F cells below 10 pg.

Tanzaniedrépanocytosepublished 2025Journal of blood medicineeurope_pmcdocument of 5 observations

30 %In Ruvuma, under-five mortality rate exceeds the expected rate by 30%.

Tanzaniemortalité infanto-juvénileHAL · Unilimdocument of 238 observations

97.9 %Mean nocturnal SpO2 was lower in 54 Tanzanian children with sickle cell anaemia (97.9%, IQR 95.4-99.3%) compared to 95 Kenyan children with sickle cell anaemia (99.0%, IQR 96.7-99.8%) and 19 Tanzanian controls (98.4%, IQR 97.5-99.1%).

Kenya · Tanzaniedrépanocytosepublished 2016Archives of disease in childhoodeurope_pmcdocument of 3 observationsDOI 10.1136/archdischild-2014-306468